Status:
ACTIVE_NOT_RECRUITING
YES Study - Newly Diagnosed/Metastatic Intervention
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborating Sponsors:
Breast Cancer Research Foundation
Conditions:
Breast Cancer
Symptom, Behavioral
Eligibility:
FEMALE
18-39 years
Phase:
NA
Brief Summary
This research study is being done to monitor common symptoms and behavior, and to provide supportive care information and peer support, as well as research opportunities for young women ages of 18-39 ...
Detailed Description
This is a prospective, interventional cohort study with an embedded Phase II randomized controlled clinical trial with a parallel design. * The research study procedures include screening for eligibi...
Eligibility Criteria
Inclusion
- Stage 0-3
- Female
- diagnosed with breast cancer between the ages of 18-39 years
- less than 3 months post diagnosis date of new primary or local recurrence (prior history of other cancer is allowed as long as treated with curative intent and no evidence of disease from that cancer)
- has not started treatment for breast cancer diagnosis yet
- is planning to get care at DFCI
- be fluent in and able to read English
- have internet access on a regular basis at the time of consent that can support the web-based platform
- Stage IV
- Female
- initial diagnosis of breast cancer between the ages of 18-39 years
- be fluent in and able to read English
- have internet access on a regular basis at the time of consent that can support the web-based platform
Exclusion
- \-
Key Trial Info
Start Date :
September 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04379414
Start Date
September 16 2020
End Date
March 1 2028
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215